The Religious Coalition for Reproductive Choice raises a different concern. They contend that restricting access to medication abortions could infringe on the religious beliefs of some patients who view abortion as a “morally acceptable choice.”
Abortion Pill Battle : A Clash of Ethics
Finally, medical associations, including the American Medical Association and the American College of Obstetricians & Gynecologists, criticize the medical associations and individual doctors challenging the FDA’s approval of mifepristone. They claim that the lawsuit prioritizes doctors’ concerns over patients, a clear violation of medical ethics and practices.
“The claim of injury is unsupported for the myriad legal reasons set forth by petitioners,” they argue.
The legal battle continues to unfold, with stakeholders on both sides deeply entrenched in their positions. The federal government is represented by Erica L. Ross, Charles L. McCloud, Michael S. Raab, and Cynthia A. Barmore, while Danco Laboratories is represented by a team from Hogan Lovells. Pharmaceutical industry group PhRMA is represented in-house, and Congress members are represented by a team from Skadden Arps Slate Meagher & Flom LLP. The medical associations are represented by legal experts from their respective organizations, as the abortion pill battle rages on.
